Endothelial Progenitor Cells
Mostrando 1-12 de 71 artigos, teses e dissertações.
-
1. Endothelial Progenitor Cells and NADPH Oxidase Enzyme Activity in the Development of an Aortic Aneurysm
Abstract Introduction: Endothelial progenitor cells (EPCs) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme activity may affect the vessel wall and have a role in development of aortic aneurysms. EPCs originate from hematopoietic stem cells and can be enumerated from peripheral blood samples by flow cytometry. In this study, we aimed t
Brazilian Journal of Cardiovascular Surgery. Publicado em: 2022
-
2. Optimizing the recovery of peripheral blood mononuclear cells trapped in leukoreduction filters - A comparison study
Abstract Introduction The isolation of captured peripheral blood mononuclear cells (PBMNCs) from leukoreduction filters (LRFs) can be of great importance in terms of bringing the lost cells back into use. Objective The aim of this study was to evaluate various methods based on their potential to recover the peripheral blood cells from LRFs with a focus on
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
3. Poly(trimethylene carbonate-co-L-lactide) electrospun scaffolds for use as vascular grafts
Currently, there is great clinical need for suitable synthetic grafts that can be used in vascular diseases. Synthetic grafts have been successfully used in medium and large arteries, however, their use in small diameter vessels is limited and presents a high failure rate. In this context, the aim of this study was to develop tissue engineering scaffolds, us
Braz J Med Biol Res. Publicado em: 12/08/2019
-
4. High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity
Abstract: Background: Behçet's disease is a multisystemic vasculitis, associated with vascular endothelial dysfunction. Currently, the prognosis is unpredictable, because there is still no valid laboratory marker indicating the disease activity in Behçet's disease. Endothelial progenitor cells and circulating endothelial cells are newly introduced hematol
An. Bras. Dermatol.. Publicado em: 29/07/2019
-
5. Endothelial progenitor cells and vascular endothelial growth factor in patients with Takayasu's arteritis
Abstract Background: Endothelial progenitor cells (EPCs) are responsible for endothelial damage repair. Takayasu's arteritis (TA) is a chronic inflammatory disease that affects large vessels. The aim of the study was to evaluate the number of EPCs and the levels of vascular endothelial growth factor (VEGF) and the relationship of these variables in patients
Adv. rheumatol.. Publicado em: 29/07/2019
-
6. Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone
Four cycles of chemotherapy are required to assess responses of multiple myeloma (MM) patients. We investigated whether circulating endothelial progenitor cells (cEPCs) could be a biomarker for predicting patient response in the first cycle of chemotherapy with bortezomib and dexamethasone, so patients might avoid ineffective and costly treatments and reduce
Braz J Med Biol Res. Publicado em: 23/06/2015
-
7. Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart disease
Remote ischemic preconditioning (RIPre) can prevent myocardial injury. The purpose of this study was to assess the beneficial effects of long-term regular RIPre on human arteries. Forty patients scheduled for coronary artery bypass graft (CABG) surgery were assigned randomly to a RIPre group (n=20) or coronary heart disease (CHD) group (n=20). Twenty pati
Braz J Med Biol Res. Publicado em: 28/04/2015
-
8. Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
It is not known whether the addition of ezetimibe to statins adds cardiovascular protection beyond the expected changes in lipid levels. Subjects with coronary heart disease were treated with four consecutive 1-week courses of therapy (T) and evaluations. The courses were: T1, 100 mg aspirin alone; T2, 100 mg aspirin and 40 mg simvastatin/10 mg ezetimibe; T3
Braz J Med Biol Res. Publicado em: 15/04/2014
-
9. Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients
OBJECTIVE: We aimed to assess the chemotactic response of endothelial progenitor cells to angiotensin-converting enzyme inhibitors in T2DM patients after acute myocardial infarction, as well as the associated prognosis. METHODS: Sixty-eight T2DM patients with acute myocardial infarction were randomized to either receive or not receive daily oral perindopr
Clinics. Publicado em: 2013-05
-
10. The level of circulating endothelial progenitor cells may be associated with the occurrence and recurrence of chronic subdural hematoma
OBJECTIVES: The onset of chronic subdural hematoma may be associated with direct or indirect minor injuries to the head or a poorly repaired vascular injury. Endothelial progenitor cells happen to be one of the key factors involved in hemostasis and vascular repair. This study was designed to observe the levels of endothelial progenitor cells, white blood c
Clinics. Publicado em: 2013
-
11. Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity
Clinics. Publicado em: 2012-09
-
12. Isolamento e caracterização de células progenitoras endoteliais de medula óssea de camundongos para utilização em terapia celular / Isolation and characterization of endothelial progenitor cells derived from bone marrow of mice for use in cell therapy
As células progenitoras endoteliais (CPEs) foram descritas por Asahara et al. (1997), isoladas a partir do sangue periférico e são células originadas da medula óssea. Estas células podem ser reconhecidas pela expressão de marcadores como o CD34, CD133, VEGFR2 e o CD31, pela capacidade de internalização de acLDL e de formar estruturas semelhantes a v
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 13/04/2011